Arrowhead Pharmaceuticals Inc. (ARWR) Reports Q1 Loss of $0.20
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Join SI Premium – FREE
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q1 EPS of ($0.20), versus ($0.03) reported last year. Revenue for the quarter came in at $21.3 million, versus $29.46 million reported last year.
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stitch Fix (SFIX) Tops Q4 EPS by 4c; Offers Guidance
- NeoVolta Inc. (NEOV) Misses Q3 EPS by 17c
- Capitol Federal Financial names William Skrobacz Jr. as president
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
